It is important to note that Retatrutide remains an investigational compound and is not yet approved by regulatory bodies like the FDA
Retatrutide represents a thrilling advancement in obesity medicine, promising weight loss results that rival surgery
Semaglutides ability to address both weight management and insulin sensitivity makes it a potentially valuable tool in PCOS management, particularly for those who haven't responded well to other treatments
This context of high prevalence, progressive natural history, and multisystemic impact underscores the urgent need for effective, broadly applicable pharmacotherapies
In phase 3 clinical trials, participants using semaglutide (2.4 mg once weekly) showed 10-15% body weight reduction on average after 68 weeks
Autophagy is a highly dynamic, multistep process involving the degradation of cytoplasmic cargo through the lysosomal machinery 51 and serves as a protective response mechanism under oxidative stress 52